IST:MEDTR Statistics
Total Valuation
IST:MEDTR has a market cap or net worth of TRY 2.12 billion. The enterprise value is 1.62 billion.
Important Dates
The next estimated earnings date is Friday, March 5, 2027.
| Earnings Date | Mar 5, 2027 |
| Ex-Dividend Date | Dec 28, 2026 |
Share Statistics
IST:MEDTR has 119.00 million shares outstanding.
| Current Share Class | 95.38M |
| Shares Outstanding | 119.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 79.41% |
| Owned by Institutions (%) | 2.72% |
| Float | 24.50M |
Valuation Ratios
The trailing PE ratio is 138.62.
| PE Ratio | 138.62 |
| Forward PE | n/a |
| PS Ratio | 0.76 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.62 |
| P/FCF Ratio | 7.33 |
| P/OCF Ratio | 4.07 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 5.32, with an EV/FCF ratio of 5.63.
| EV / Earnings | 106.35 |
| EV / Sales | 0.58 |
| EV / EBITDA | 5.32 |
| EV / EBIT | 15.66 |
| EV / FCF | 5.63 |
Financial Position
The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.77 |
| Quick Ratio | 2.40 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.08 |
| Interest Coverage | 5.37 |
Financial Efficiency
Return on equity (ROE) is 0.62% and return on invested capital (ROIC) is 3.61%.
| Return on Equity (ROE) | 0.62% |
| Return on Assets (ROA) | 1.73% |
| Return on Invested Capital (ROIC) | 3.61% |
| Return on Capital Employed (ROCE) | 2.91% |
| Weighted Average Cost of Capital (WACC) | 7.39% |
| Revenue Per Employee | 3.65M |
| Profits Per Employee | 19,885 |
| Employee Count | 761 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.74 |
Taxes
| Income Tax | -88.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.31% in the last 52 weeks. The beta is 0.45, so IST:MEDTR's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -35.31% |
| 50-Day Moving Average | 19.13 |
| 200-Day Moving Average | 26.11 |
| Relative Strength Index (RSI) | 41.71 |
| Average Volume (20 Days) | 247,354 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:MEDTR had revenue of TRY 2.80 billion and earned 15.27 million in profits.
| Revenue | 2.80B |
| Gross Profit | 927.79M |
| Operating Income | 107.52M |
| Pretax Income | -68.43M |
| Net Income | 15.27M |
| EBITDA | 300.00M |
| EBIT | 107.52M |
| Earnings Per Share (EPS) | n/a |
Full Income Statement Balance Sheet
The company has 547.80 million in cash and 24.33 million in debt, with a net cash position of 523.47 million or 4.40 per share.
| Cash & Cash Equivalents | 547.80M |
| Total Debt | 24.33M |
| Net Cash | 523.47M |
| Net Cash Per Share | 4.40 |
| Equity (Book Value) | 3.55B |
| Book Value Per Share | n/a |
| Working Capital | 1.55B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 520.66 million and capital expenditures -231.94 million, giving a free cash flow of 288.72 million.
| Operating Cash Flow | 520.66M |
| Capital Expenditures | -231.94M |
| Depreciation & Amortization | 192.48M |
| Net Borrowing | -19.78M |
| Free Cash Flow | 288.72M |
| FCF Per Share | 2.43 |
Full Cash Flow Statement Margins
Gross margin is 33.14%, with operating and profit margins of 3.84% and 0.55%.
| Gross Margin | 33.14% |
| Operating Margin | 3.84% |
| Pretax Margin | -2.44% |
| Profit Margin | 0.55% |
| EBITDA Margin | 10.72% |
| EBIT Margin | 3.84% |
| FCF Margin | 10.31% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 1.42%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 1.42% |
| Dividend Growth (YoY) | 35.01% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 275.17% |
| FCF Payout Ratio | 14.03% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.42% |
| Earnings Yield | 0.72% |
| FCF Yield | 13.64% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on February 22, 2022. It was a forward split with a ratio of 3.5.
| Last Split Date | Feb 22, 2022 |
| Split Type | Forward |
| Split Ratio | 3.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |